April 28-29: Forum

Join us in charting the best path forward in cross-disciplinary collaborations that drive innovative approaches to clinical trial design and execution. A unique forum of experts involved in clinical development, including biostatisticians, clinical researchers, technology experts, and regulators, will discuss cross-disciplinary team science, regulatory guidance updates, and lessons learned from case studies of innovative clinical trial designs to set the stage for a multi-stakeholder dialogue that resolves barriers to progress and facilitates transformative change.

The revamped 2025 forum will:
Present case studies and lessons learned from oncology and neuroscience; Provide subsequent roundtable discussions on master protocols, complex innovative designs (CIDs), and external data burrowing to assess bottlenecks and create solutions; Lead to the publication of each roundtable’s findings and recommendations and concrete next steps towards continued collaborative work.

The forum is designed for professionals involved in medical product development, including biostatisticians, physicians, clinical researchers and clinical operations professionals, regulators, technology experts from the pharmaceutical and biotechnology industry, academics, representatives from nonprofits and the federal government, contract research organizations, and other vendors.